ECG Leadwires: Disposable Versus Cleaned, Reusable
ECG-LW
ECG Leadwires: Do Disposable Leadwires Reduce the Incidence of Bacterial Infections in ICU Patients and Provide Adequate Signaling in Stepdown/Telemetry Environment Compared to Cleaned Reusable ECG Leadwires?
1 other identifier
interventional
4,056
1 country
1
Brief Summary
Null hypothesis: (1) there is no difference in rates of ICU-acquired infection based on using disposable or cleaned, reusable ECG leadwires and (2) In cardiac surgical telemetry floors, there is no difference in false or nuisance sightings or crisis calls based on using disposable or cleaned, reusable ECG leadwires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 5, 2011
CompletedFirst Posted
Study publicly available on registry
August 8, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFebruary 23, 2016
February 1, 2016
1.3 years
August 5, 2011
February 21, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood stream infection
culture findings
7 months
Secondary Outcomes (1)
false/nuisance alarms
4 months
Study Arms (2)
Reusable ECG leadwires-ICU
NO INTERVENTIONCurrent ECG leadwires will be used
Disposable ECG leadwires-ICU
ACTIVE COMPARATORDisposable ECG-LW
Interventions
Disposable ECG leadwires used in ICU and telemetry monitoring; 5 lead sets for ICU and 6-lead sets for telemetry
Eligibility Criteria
You may qualify if:
- Primary HO: patients treated in an ICU setting; Secondary HO: Patients treated in cardiac telemetry setting
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy M Albert, PhD
The Cleveland Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Director, Nursing Research and Innovation
Study Record Dates
First Submitted
August 5, 2011
First Posted
August 8, 2011
Study Start
September 1, 2011
Primary Completion
December 1, 2012
Study Completion
February 1, 2013
Last Updated
February 23, 2016
Record last verified: 2016-02